CLINICAL_TRIALS
trial_result
· 2020-05-01
Clinical Trial Update: Vortioxetine for Binge Eating Disorder [Phase 2]
Summary
Phase 2 clinical trial evaluating vortioxetine for binge eating disorder has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Binge Eating Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-05-01